• News
  • BioTech

Mallinckrodt to Buy Questcor in $5.6 Billion Drugs Deal

April 7 (Bloomberg) -- Mallinckrodt Plc agreed to buy Questcor Pharmaceuticals Inc. for $5.6 billion to add specialty drugs in the latest industry deal that moves a U.S. company to Ireland for a lower tax rate.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!